Age no bar to benefits of lung cancer chemo

	Tweet

New research strongly suggests that advanced age alone should not preclude an elderly patient with non-small cell lung cancer (the most common type) from receiving chemotherapy.

According to a report in the journal Chest, chemotherapy tends to be as effective and well tolerated among elderly patients with non-small cell lung cancer as it is in their younger counterparts.

Non-small cell lung cancer, one of the deadliest and poorly treated types of cancer, is a typical disease of the elderly, with a peak incidence at around 70 to 80 years of age.

Elderly patients, say study investigators, may be treated suboptimally, and their participation in clinical trials is less than that among younger patients, even though their age group experiences a higher incidence of lung cancer.

Dr. Yuh-Min Chen, at the Taipei Veterans General Hospital, and colleagues reviewed three clinical trials they had conducted among patients with non-small cell lung cancer, comparing outcomes among patients age 70 years and older with those of younger patients.

In all three trials, response rates and survival times were not markedly different between older patients and younger patients, leading Chen’s team to conclude, “age itself should not preclude an elderly patient from receiving chemotherapy."

Treatment choices should be based on “clinical sense,” they add, as well as what is known about the toxicity of chemotherapy agents, patient comorbidities, cost considerations and patient preferences.

SOURCE: Chest, July 2005.

RELATED STORIES:
Lung cancer research concludes that early diagnosis as key for improving survival   New research confirms need for lung cancer testing   New Test Promises Quicker, More Accurate Evaluation for Cystic Fibrosis Patients   Study shows way to predict lung cancer recurrence   Heaviest Smokers Face Greatest Risk of Death After Lung Cancer Diagnosis   Secondhand smoke exposure in childhood increases lung cancer risk later in life   Non-Smokers with lung cancer respond better to treatment than smokers   Study Helps Explain Why Black Patients with Lung Cancer Have Surgery Less Often than Whites   Potential Early Warning System for Lung Cancer Identified   Learn the Signs and Symptoms of Lung Cancer   Celecoxib may prevent lung cancer in former smokers   New lung cancer staging system revealed   Asian lung cancer patient survival exceeds Caucasians’ on multiple regimens   Psychiatric symptoms can be first sign of cancer   Lung cancer tied to family risk of other cancers   Value of CT screening for lung cancer unclear   Eating a variety of fruit cuts lung cancer risk   Guide on Lung Cancer in “Never-smokers”: a Different Disease and Different Treatments   Missing protein may hold lung cancer key   Gene Expression Profiling Advance for Lung Cancer Prognosis   Gene combination increases risk of lung cancer, particularly in light smokers, CAMH study finds   High-fiber diet linked to lower lung disease risk

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]